Zepbound in Canada went from Health Canada authorization on May 13, 2025 to pharmacy shelves by July 9, 2025, one of the faster launches a weight-loss drug has had in this country [1]. Since then it has become the medication Canadian readers ask us about most. I wrote this guide as the single starting point: what tirzepatide is, who qualifies, what it costs, and what the first year actually feels like. Grab a coffee. This one is long on purpose.
Once you finish here, the detailed pages go further: pricing dose by dose, how to get a prescription, and the side effect timeline.
What Is Zepbound?
Zepbound is the brand name for tirzepatide sold for chronic weight management. Health Canada authorized it for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition [1]. It is also approved for obstructive sleep apnea in adults with obesity [2]. If the molecule sounds familiar, that is because it is the same one in Mounjaro. Mounjaro carries the type 2 diabetes label, Zepbound carries the weight-loss label, and both come in the same six doses [1]. Our Mounjaro hub covers the diabetes side of the same molecule.
Zepbound sells only as a multi-dose KwikPen in Canada. One pen holds four weekly injections, so one pen equals a four-week supply [3]. There are no single-dose pens and no vials at Canadian pharmacies, which keeps the buying math simple: one pen, one four-week cycle.
How Tirzepatide Works
Tirzepatide is a dual receptor agonist. It activates the GIP receptor and the GLP-1 receptor at the same time, two gut hormone pathways tied to appetite and blood sugar [3]. Semaglutide, the molecule in Ozempic and Wegovy, targets GLP-1 alone. In plain language: the drug slows how fast your stomach empties, quiets appetite signalling in the brain, and helps your body manage glucose. Most patients describe the effect as food noise going silent. You still eat; you just stop thinking about food all day. That dual action is why Lilly calls Zepbound the first and only dual receptor agonist approved for obesity treatment in Canada [1].
What the SURMOUNT Trials Showed
Health Canada based its decision on the SURMOUNT clinical trial program [1]. Across those trials, adults taking tirzepatide alongside diet and exercise lost meaningfully more weight than adults on placebo, and higher doses produced larger average losses [3]. I will not quote one headline percentage here, because results ranged across trials, doses and time points. The product monograph publishes the full tables if you want the raw data [3].
Two honest caveats. Trial participants got regular check-ins and structured lifestyle support that the average patient will not get at a walk-in clinic. And weight tends to come back when the drug stops, which is exactly why Health Canada approved it for chronic management rather than a short course [3]. Go in planning for the long haul, both medically and financially.
Zepbound Dosing Schedule
Everyone starts at 2.5 mg once weekly. That starter dose exists for tolerance, not for results, and after four weeks the monograph moves patients up to 5 mg [3]. From there the dose can rise in 2.5 mg steps, each held for at least four weeks as tolerated, to a maximum of 15 mg [3]. Here is how the strengths map to Lilly's price tiers [4]:
| Dose | Role in the schedule | List price per pen |
|---|---|---|
| 2.5 mg | Starter, weeks 1 to 4 | $300 |
| 5 mg | First maintenance dose | $300 |
| 7.5 and 10 mg | Step-up doses | $420 |
| 12.5 and 15 mg | Highest maintenance doses | $540 |
Not everyone needs 15 mg. Plenty of patients hold at 5 or 10 mg, and the pricing tiers reward staying at the lowest dose that works for you. That is a conversation to have with your prescriber at every follow-up, not a ladder you are obligated to climb.
Zepbound vs Ozempic: The Head-to-Head
| Zepbound | Ozempic | |
|---|---|---|
| Molecule | Tirzepatide, dual GIP and GLP-1 | Semaglutide, GLP-1 only |
| Canadian label | Chronic weight management, plus sleep apnea with obesity | Type 2 diabetes |
| Format | Multi-dose KwikPen, weekly injection | Pre-filled pen, weekly injection |
| List price | $300 to $540 per 4-week pen | Varies; confirm with your pharmacy |
| Generic available | No | Yes, generic semaglutide injection at about $88 to $120/month |
The label difference matters more than most people expect, because insurers read labels, not intentions. A diabetes prescription and a weight-loss prescription travel through completely different coverage rules. Our full Zepbound vs Ozempic comparison digs into the trial data and the switching questions.
Who Qualifies for Zepbound in Canada
- BMI of 30 or higher: the adult threshold used across the SURMOUNT program [1].
- BMI of 27 or higher plus a weight-related condition: conditions like high blood pressure count; your prescriber makes the call [1].
- Obstructive sleep apnea with obesity: Zepbound holds a separate Health Canada indication here [2].
You need a prescription either way. Any licensed physician or nurse practitioner can write one, and telehealth visits count. Our how-to-get guide maps the family doctor route against the online route, step by step, including what to do if your doctor says no.
What to Expect Month by Month
Months 1 and 2: The Adjustment
You start at 2.5 mg, and this stretch is about your gut making peace with the drug. Appetite drops for most people within the first weeks, and mild nausea or constipation is common while doses climb [3]. Eat smaller meals, stay hydrated, and keep expectations modest on the scale for now.
Months 3 to 6: Finding Your Dose
Dose increases continue every four weeks or slower, depending on how you tolerate each step [3]. This is where you and your prescriber find the strength that balances results against side effects and price. Many people never pass 10 mg, and that is fine.
Months 6 to 12: The Long Game
The work shifts from titration to habits. Appointments spread out, refills become routine, and budgeting starts to matter more than novelty. Remember the pen math: a full year of weekly injections takes 13 four-week pens, not 12, so plan the budget around 13 fills.
Side Effects at a Glance
The common ones are digestive: nausea, diarrhea, constipation and vomiting, most often around dose increases [3]. Rare but serious risks include pancreatitis and gallbladder problems, and the monograph carries a warning about thyroid C-cell tumours seen in rodent studies; anyone with a personal or family history of medullary thyroid carcinoma should not take tirzepatide [3]. Our side effects guide covers management dose by dose, plus what Canadian patients report in the real world.
What Zepbound Costs
Short version: $300 to $540 per four-week pen at Lilly list prices, set on December 29, 2025 after a cut of more than 20 percent [4]. Business coverage confirmed the reduction across Lilly's Canadian tirzepatide lineup [5]. At the counter, Costco often sells starter pens below list, around $279 to $283, while Shoppers Drug Mart and Rexall run above it, so expect roughly $280 to $370 for the 2.5 and 5 mg pens depending on the pharmacy. No provincial plan pays for weight-loss GLP-1s, though BC PharmaCare has Zepbound under formal review [6], and about 31 percent of Canadian employer plans include some GLP-1 weight-loss coverage [7]. The full pricing page breaks it down dose by dose, and the cheapest options page ranks every way to pay less.
A Cheaper Option: Generic Semaglutide
There is no generic Zepbound and no generic tirzepatide, and none is expected for years. If cost is the deciding factor, generic semaglutide, the generic of Ozempic, now sells for about $88 to $120 a month at Canadian pharmacies, and MyRocky offers it online at $149 a month all-in. It is a different molecule and a weekly injection, so this is a prescriber conversation, not a pharmacy swap. Our generic semaglutide guide has the full price comparison.
The myZepbound Savings Program
Lilly's Canadian program lets residents self-enroll at myzepbound.ca or by phone at 1-833-382-8639 [8]. Without private insurance, it lets you start Zepbound for as low as about $300 a month. With private coverage, Lilly says patients pay under $1 a day on average, roughly $30 a month [8]. It also bundles prior authorization and reimbursement help. Our savings card guide covers enrollment and the fine print.
Online Providers Cost Comparison
A quick accuracy note before the table: MyRocky prescribes and fills Zepbound (tirzepatide) online, plus generic semaglutide from $149 a month as a lower-cost option. Our MyRocky review has the full service breakdown.
| Provider | Tirzepatide access | Consult fee | Get started |
|---|---|---|---|
| MyRocky ⭐ Top Pick | Zepbound (tirzepatide), plus generic semaglutide from $149/month | $99 one time, includes lab work | Visit MyRocky |
| Felix Health | GLP-1 weight-loss program; confirm current Zepbound availability at intake | Program fees vary by plan | Visit Felix |
| Maple | General telehealth; the doctor can send a Zepbound prescription to your local pharmacy | Per-visit fee | Book through the Maple app |
| Hims & Hers Canada | Weight-loss GLP-1 program, confirm tirzepatide | Consult and program fees vary | Read our Hims review |
| Phoenix | Men's telehealth for weight-loss GLP-1s, confirm tirzepatide | Consult fees vary | Read our Phoenix review |
| Raven | Women's telehealth for weight-loss GLP-1s, confirm tirzepatide | Consult fees vary | Read our Raven review |
FAQ
Is Zepbound available in Canada?
Yes. Zepbound has been on Canadian pharmacy shelves since July 9, 2025, following Health Canada authorization that May [1].
Is Zepbound the same as Mounjaro?
Same molecule, different label. Both are tirzepatide in a KwikPen at the same six doses; Mounjaro is labelled for type 2 diabetes and Zepbound for weight management [1].
How much weight will I lose on Zepbound?
There is no single number. Trial results varied by dose and duration, and your habits, health history and final dose all move the needle. The product monograph carries the full SURMOUNT tables, and your prescriber can set expectations for your case [3].
Do I need a prescription for Zepbound in Canada?
Yes. Tirzepatide is prescription-only in Canada. Any site selling it without a prescription operates outside Health Canada rules, and you cannot verify what is actually in the pen.
Will insurance cover Zepbound?
No public plan covers it for weight loss as of mid-2026. About 31 percent of employer plans include some GLP-1 weight-loss coverage, almost always behind prior authorization [7]. Our coverage guide shows how to check your plan in ten minutes.
Can I start Zepbound through telehealth?
Yes. Weight-loss telehealth operates in every province. Just know that MyRocky prescribes the molecule as Mounjaro rather than Zepbound, and Felix confirms drug availability at intake, so ask each service what lands in your fridge before you pay a consult fee.
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing and coverage directly with the pharmacy and your insurer before filling.
Sources
- Zepbound KwikPen (tirzepatide injection) now approved and available in Canada: Lilly Canada launch announcement via Newswire, July 9, 2025, including indication and SURMOUNT background.
- Zepbound receives Notice of Compliance for obstructive sleep apnea: Lilly Canada press release on the sleep apnea indication.
- Zepbound Product Monograph: Lilly Canada monograph covering mechanism, dosing schedule, trial results and safety warnings.
- Eli Lilly & Co. cuts price of popular diabetes and weight-loss drugs in Canada: The Globe and Mail report on the list prices effective December 29, 2025.
- Eli Lilly cuts Canadian obesity drug prices: Benefits and Pensions Monitor coverage of the December 2025 price reduction.
- Tirzepatide (Zepbound) drug information sheet, submission 4166: Government of British Columbia PharmaCare review record.
- Are weight-loss medications covered in Canada?: PolicyAdvisor data on employer plan GLP-1 coverage rates.
- Zepbound KwikPen patient support and savings FAQ: Lilly Canada details on myZepbound program pricing and enrollment.